Search

Your search keyword '"Trezzi, M."' showing total 215 results

Search Constraints

Start Over You searched for: Author "Trezzi, M." Remove constraint Author: "Trezzi, M."
215 results on '"Trezzi, M."'

Search Results

1. Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine

2. When rational functions meet virtual elements: The lightning Virtual Element Method

3. CIP-stabilized Virtual Elements for diffusion-convection-reaction problems

4. Diagnostic role of internal mammary lymph node involvement in tuberculous pleurisy: a multicenter study

5. Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine

6. The effect of switching to Maraviroc + Darunavir/ritonavir dual therapy in virologically suppressed patients on the progression of liver fibrosis: findings from a randomized study

7. 18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infectionsA case series on the use of Nuclear Medicine in NTM-PD

8. Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort

9. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

10. Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: The X-COVID-19 Randomized Trial

11. The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey

12. Diagnostic role of internal mammary lymph node involvement in tuberculous pleurisy: a multicenter study

13. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

14. Prediction of Italian ryegrass (Lolium multiflorum L.) emergence using soil thermal time

15. Demographics of glyphosate-resistant and susceptible Italian ryegrass populations from Paraná

18. Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients

22. Modeling the Population Dynamics and Management of Italian Ryegrass under Two Climatic Scenarios in Brazil

25. Desarrollo y validación de un modelo termal para describir la emergencia de Lolium multiflorum

26. Clinical, epidemiological and virological features of acute hepatitis B in Italy

27. Desarrollo y validación de un modelo termal para describir la emergencia de Lolium multiflorum

28. Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe

29. Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: Predictors of virological response and drug resistance evolution in a multi-cohort study

30. Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis

31. No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy

32. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

33. Relação de interferência mútua entre plantas daninhas e sete cultivares de feijão do grupo Carioca

34. Competitive ability of black Common Bean genotypes with weeds

36. Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010

37. A novel methodology for large-scale phylogeny partition

38. Vascular Complications following Isolated Limb Perfusion for Local Recurrence of Extremity Melanoma: A Case Report and Literature Review

39. A novel methodology for large-scale phylogeny partition

40. Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study

41. A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen

42. Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI

43. Low Rate of Virological Failure and Maintenance of Susceptibility to HIV-1 Protease Inhibitors with First-Line Lopinavir/Ritonavir-Based Antiretroviral Treatment in Clinical Practice

44. Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice

45. Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting

46. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

48. Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study

49. Prevalence of Tuberculosis infection among teen-agers in Tuscany

Catalog

Books, media, physical & digital resources